Nanyang Technological University Singapore
About Us
Students
Programme
Undergraduate
Current Students
Prospective Students
Graduate
Current Students
Prospective Students
People
Faculty
Administrative Staff
Alumni
Research
Safety
Facilities and Services
Career
News
Events
Giving
Home / School of Chemistry, Chemical Engineering and Biotechnology (CCEB) / News

From Early Detection to Targeted Therapy: NTU Team Reports New Cancer Research Breakthrough

Published on 30 Mar 2026

Researchers led by Prof Kanyi Pu at Nanyang Technological University, Singapore (NTU Singapore) have reported two advances that address a persistent challenge in cancer care: translating in vivo biological activity into measurable signals that can be read quickly and sensitively, including at clinically relevant tissue depths, without complex workflows.

In cancer treatment, chemotherapy remains one of the most commonly used therapeutic approaches. However, while potent drug treatment can suppress tumors, it may also cause severe kidney injury. In current clinical practice, there is still a lack of simple methods that can simultaneously evaluate therapeutic efficacy and treatment-related toxicity. To address this challenge, the Pu team reported a urine-based in vitro detection strategy in Nature Biomedical Engineering that can track both chemotherapy response and treatment-related kidney injury at the same time. By leveraging bioorthogonal chemistry, the system enables precise probe activation only in the presence of specific biomarkers, thereby achieving high sensitivity and specificity. This work provides a more convenient and noninvasive approach for dynamic monitoring during cancer treatment, and also shows strong potential for future home-based testing and long-term patient follow-up.

Radiotherapy is widely used in cancer treatment because of its strong tissue penetration and high tumour-killing efficiency. Yet its clinical use is often limited by collateral damage to healthy tissues. In work published in Nature Nanotechnology, the Pu team tackled this challenge by developing a smart nanoprobe that produces tumour-specific signals, enabling ultrasensitive detection and the surgical removal of very small tumours under a low X-ray dose. This design improves therapeutic efficiency without causing unnecessary damage to surrounding healthy tissue, leading to prolonged survival and fewer radiation-related side effects, provides a new molecular design strategy for precision cancer radiotherapy.

These two studies highlight the Pu team’s broader vision of advancing cancer care through innovative molecular design, offering new possibilities for safer, smarter, and more precise diagnosis and treatment.

Please click below to read the full publications:

Kidney injury | Radiotherapy

 


 

Share this article:

Other News

View All
Photo of Emily Xi Tan
24 Sep 2026

Emily Xi Tan receives 2026 IUPAC-Solvay International Award for Young Chemists

photo of cceb phd graduate cheng yu
27 Aug 2026

Cheng Yu’s PhD Quest to Redefine Cancer Therapy

18 Nov 2026

Fishing for Lithium in Seawater Brine

1 of 1
View All
Nanyang Technological University Singapore

Follow Us

About Us

Students

  • Programme
  • Undergraduate
    • Current Students
    • Prospective Students
  • Graduate
    • Current Students
    • Prospective Students

People

  • Faculty
  • Administrative Staff
  • Alumni

Research

  • Safety
  • Facilities and Services

Career

News

Events

Giving

© 2026 Nanyang Technological University